Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Circulation

Showing results (451-460 of 44,164) with videos related to

Pageof 4,417
Sort By:
Circulation|June 5, 2002
Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirinRajesh K Kharbanda, Benjamin Walton, Meredith Allen, et al.
Circulation|June 5, 2002
Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trialPeter Wiesli, Wolfgang Czerwenka, Alfredo Meniconi, et al.
Circulation|June 5, 2002
Electrophysiology and arrhythmogenic activity of single cardiomyocytes from canine superior vena cavaYi-Jen Chen, Yao-Chang Chen, Hung-I Yeh, et al.
Circulation|June 5, 2002
Inflammation-sensitive proteins: another ingredient in stroke?Ruth SoRelle
Circulation|May 8, 2002
Cardiology patient pages. Cardiac pacemakers from the patient's perspectiveMark A Wood, Kenneth A Ellenbogen
Circulation|May 8, 2002
Characteristics of wavefront propagation in reentrant circuits causing human ventricular tachycardiaAnthony W C Chow, Richard J Schilling, D Wyn Davies, et al.
Circulation|May 8, 2002
Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathwayDinesh Kalra, Natarajan Sivasubramanian, Douglas L Mann
Circulation|May 8, 2002
Mineralocorticoid receptor antagonism in experimental atherosclerosisSanjay Rajagopalan, Damon Duquaine, Steven King, et al.
Circulation|May 8, 2002
Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart AssociationScott M Grundy, Barbara Howard, Sidney Smith, et al.
Circulation|May 9, 2002
Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive proteinSubodh Verma, Shu-Hong Li, Mitesh V Badiwala, et al.
Pageof 4,417

Showing results (451-460 of 44,164) with videos related to

Sort By:
Pageof 4,417
Circulation|June 5, 2002
Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirinRajesh K Kharbanda, Benjamin Walton, Meredith Allen, et al.
Circulation|June 5, 2002
Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trialPeter Wiesli, Wolfgang Czerwenka, Alfredo Meniconi, et al.
Circulation|June 5, 2002
Electrophysiology and arrhythmogenic activity of single cardiomyocytes from canine superior vena cavaYi-Jen Chen, Yao-Chang Chen, Hung-I Yeh, et al.
Circulation|June 5, 2002
Inflammation-sensitive proteins: another ingredient in stroke?Ruth SoRelle
Circulation|May 8, 2002
Cardiology patient pages. Cardiac pacemakers from the patient's perspectiveMark A Wood, Kenneth A Ellenbogen
Circulation|May 8, 2002
Characteristics of wavefront propagation in reentrant circuits causing human ventricular tachycardiaAnthony W C Chow, Richard J Schilling, D Wyn Davies, et al.
Circulation|May 8, 2002
Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathwayDinesh Kalra, Natarajan Sivasubramanian, Douglas L Mann
Circulation|May 8, 2002
Mineralocorticoid receptor antagonism in experimental atherosclerosisSanjay Rajagopalan, Damon Duquaine, Steven King, et al.
Circulation|May 8, 2002
Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart AssociationScott M Grundy, Barbara Howard, Sidney Smith, et al.
Circulation|May 9, 2002
Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive proteinSubodh Verma, Shu-Hong Li, Mitesh V Badiwala, et al.
Pageof 4,417